WALTHAM, Mass.–PerkinElmer, Inc. (NYSE: PKI), today announced the appointment of Daniel R. Marshak, Ph.D., to the additional position of president of its Greater China operations. In this role, Marshak will assume overall leadership of PerkinElmer in Greater China, and will be responsible for expanding its resources in the region to drive innovation and new product introductions. He will be based out of Shanghai, strengthening the Company’s executive and scientific presence in the country. Marshak will continue in his role as senior vice president and chief scientific officer for the Company.

“We recognize the importance of increasing our leadership throughout the world to drive the growth of our business globally and to support the rapidly expanding health and environmental infrastructures of emerging nations, including China,” said Robert F. Friel, president and chief executive officer, PerkinElmer. “Dan is a seasoned executive with deep scientific expertise. His presence in China will enable us to leverage our scientific leadership in a region where we see significant opportunity for growth, and help us better meet the changing needs of our customers in the country and throughout the Asia-Pacific region.”

China represents a key market for PerkinElmer, with significant growth opportunities in areas such as environmental monitoring, diagnostics, medical and industrial imaging. PerkinElmer has been partnering with China for more than 20 years and currently employs approximately 1,200 people in Shanghai, Beijing, Guangzhou, Chengdu, Wuhan, Shenyang and Shenzhen. The October 2007 opening of PerkinElmer’s 7,000 square foot EcoAnalytix™ application and technical center in Shanghai represents the Company’s most recent expansion in the Greater China region.

PerkinElmer, Inc. is a global technology leader driving growth and innovation in Health Sciences and Photonics markets to improve the quality of life. The Company reported revenues of $1.8 billion in 2007, has 9,100 employees serving customers in more than 150 countries, and is a component of the S&P 500 Index. Additional information is available through www.perkinelmer.com or 1-877-PKI-NYSE.